Steven L. Shafer
Corporate Officer/Principal bei Stanford University
Profil
Steven L.
Shafer was the founder of Signature Therapeutics, Inc. founded in 2004, where he held the title of Head-Medical Affairs.
Currently, he holds the position of Professor at both Stanford University and The University of California, San Francisco.
Dr. Shafer's education includes a doctorate from Stanford University and an undergraduate degree from Princeton University.
Aktive Positionen von Steven L. Shafer
Unternehmen | Position | Beginn |
---|---|---|
Stanford University | Corporate Officer/Principal | - |
The University of California, San Francisco | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Steven L. Shafer
Unternehmen | Position | Ende |
---|---|---|
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Signature Therapeutics, Inc. develops and manufactures pharmaceutical products. It focuses on developing medications for use in pain management and ADHD. Its proprietary BIO-MD platform is designed to deter prescription drug abuse by virtue of strong chemical bonds within the prodrug and also offers solution to the ongoing epidemic of prescription opioid drug abuse. The company was founded by Steven L. Shafer in 2004 and is headquartered in Palo Alto, CA. | Gründer | - |
Ausbildung von Steven L. Shafer
Stanford University | Doctorate Degree |
Princeton University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Signature Therapeutics, Inc. develops and manufactures pharmaceutical products. It focuses on developing medications for use in pain management and ADHD. Its proprietary BIO-MD platform is designed to deter prescription drug abuse by virtue of strong chemical bonds within the prodrug and also offers solution to the ongoing epidemic of prescription opioid drug abuse. The company was founded by Steven L. Shafer in 2004 and is headquartered in Palo Alto, CA. | Health Technology |